CBD and Sleep
What the evidence actually says about cannabidiol for insomnia, sleep quality, and sleep disorders.
CBD is marketed as a natural sleep aid, but the science is thinner than the wellness industry suggests. The best controlled trials show CBD helps some people with anxiety-driven sleeplessness and certain neurological conditions, but it is not a proven hypnotic. Many positive consumer reports likely involve THC, melatonin, or expectancy. If you sleep better on a 'CBD' gummy, check the label — many contain other actives. Dose, formulation, and what's keeping you awake matter more than the molecule itself.
Not Medical Advice
This article is for education, not medical advice. Sleep problems can be symptoms of serious conditions (sleep apnea, depression, thyroid disease, medication side effects). Talk to a clinician before self-treating with CBD, especially if you take other medications — CBD interacts with many drugs through liver enzymes (CYP3A4, CYP2C19) Strong evidence[1].
Plain-Language Summary
CBD (cannabidiol) is a non-intoxicating cannabinoid. People buy it for sleep, but the evidence that pure CBD is a reliable sleep aid is weaker than marketing implies. Where it seems to help most is indirectly: by reducing anxiety in people whose racing thoughts keep them awake Weak / limited[2][3]. For straightforward insomnia in otherwise healthy adults, controlled trials are small and mixed Weak / limited[4]. Many over-the-counter 'CBD sleep' products also contain melatonin, CBN, or trace THC — and those ingredients, plus the placebo effect, may be doing much of the work Disputed[5].
What Probably Works
Nothing about CBD for sleep meets the 'strong evidence' bar yet. The closest thing is the indirect pathway through anxiety. A frequently cited 2019 retrospective case series at a psychiatric clinic found that 66.7% of patients given 25–75 mg CBD reported improved sleep scores within the first month, though scores fluctuated over time Weak / limited[2]. A 2019 randomized trial of 300 mg CBD before a public-speaking task reduced anxiety, which is the upstream mechanism people are betting on Weak / limited[3].
For a narrow medical use — seizure-related sleep disruption in Dravet and Lennox-Gastaut syndromes — pharmaceutical CBD (Epidiolex) improved sleep secondarily to seizure reduction Strong evidence[6]. This does not generalize to healthy adults buying gummies.
What Might Work
- Anxiety-driven insomnia. Moderate oral doses (25–75 mg) in the evening, in people whose primary problem is rumination Weak / limited[2].
- REM sleep behavior disorder in Parkinson's disease. A small open-label study (n=4) suggested CBD reduced symptom frequency Weak / limited[7]. This is preliminary.
- Sleep in chronic pain conditions. If CBD reduces pain (itself only weakly supported for most conditions), sleep may improve as a downstream effect Weak / limited[8].
- High-dose CBD for sedation. Some early work suggested 160 mg or higher had sedative effects, while lower doses (15 mg) were mildly alerting Weak / limited[4]. Dose-response is non-linear and poorly mapped.
What Doesn't Work or Has Weak Evidence
- Low-dose CBD (5–15 mg) as a standalone hypnotic. No convincing controlled evidence. Most '10 mg gummy' products fall here No data.
- CBD for obstructive sleep apnea. No good evidence. Apnea is a mechanical/neurological airway problem; CBD will not fix it. Use CPAP and see a sleep physician.
- 'Indica' CBD products vs. 'sativa' CBD products for sleep. The indica/sativa distinction does not reliably predict effects Disputed[9]. See Indica vs Sativa: The Myth.
- CBD + melatonin as 'better than melatonin.' No head-to-head trials show the CBD adds meaningful benefit over melatonin alone No data.
- Topical CBD for sleep. Transdermal absorption is poor; systemic levels are negligible Weak / limited[10].
What We Don't Know
- The optimal dose, timing, and formulation (isolate vs. broad spectrum vs. full spectrum) for sleep.
- Whether long-term nightly use causes tolerance, rebound insomnia on discontinuation, or changes in sleep architecture.
- How much of the reported benefit is the entourage of trace THC and minor cannabinoids (especially CBN, which is heavily marketed for sleep but has almost no human trial data) vs. CBD itself No data.
- Whether CBD affects sleep stages (REM, slow-wave) meaningfully in healthy adults. Existing polysomnography data is sparse and inconsistent Weak / limited[4].
Comparison with Standard Treatments
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment for chronic insomnia, recommended by the American College of Physicians and the American Academy of Sleep Medicine Strong evidence[11]. It outperforms medications long-term and has no side effects. CBD has not been compared head-to-head against CBT-I.
Prescription hypnotics (zolpidem, eszopiclone, doxepin, suvorexant) have robust efficacy data but carry dependence, next-day impairment, or fall risks. CBD has a milder side-effect profile but much weaker efficacy data.
Melatonin has modest, well-replicated effects for circadian-rhythm problems and sleep-onset latency Strong evidence[12]. For most sleep complaints, melatonin has better evidence than CBD at a fraction of the cost.
Bottom line: if you have chronic insomnia, CBT-I first. CBD is, at best, an adjunct.
Risks and Interactions
CBD is generally well-tolerated but is not inert:
- Drug interactions. CBD inhibits CYP3A4 and CYP2C19. It can raise blood levels of warfarin, clobazam, certain statins, tacrolimus, and others Strong evidence[1][6]. Check with a pharmacist.
- Liver enzyme elevations. Documented at higher doses in epilepsy trials Strong evidence[6].
- Sedation, diarrhea, appetite changes at higher doses.
- Product quality. Independent testing repeatedly finds mislabeled CBD products — under-dosed, over-dosed, or containing undeclared THC Strong evidence[13]. A 'CBD' product testing positive on a drug test is a known problem.
- Pregnancy. The FDA advises against CBD use in pregnancy and breastfeeding Strong evidence[14].
Sources
- Peer-reviewed Brown JD, Winterstein AG. Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. J Clin Med. 2019;8(7):989.
- Peer-reviewed Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in Anxiety and Sleep: A Large Case Series. Perm J. 2019;23:18-041.
- Peer-reviewed Linares IM, Zuardi AW, Pereira LC, et al. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry. 2019;41(1):9-14.
- Peer-reviewed Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Curr Psychiatry Rep. 2017;19(4):23.
- Reported Grinspoon P. Cannabidiol (CBD) — what we know and what we don't. Harvard Health Publishing, Harvard Medical School, updated 2024. ↗
- Peer-reviewed Devinsky O, Cross JH, Laux L, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017;376(21):2011-2020.
- Peer-reviewed Chagas MH, Eckeli AL, Zuardi AW, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series. J Clin Pharm Ther. 2014;39(5):564-6.
- Peer-reviewed National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
- Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis Cannabinoid Res. 2016;1(1):44-46.
- Peer-reviewed Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol. J Pharm Pharmacol. 2004;56(3):291-7.
- Peer-reviewed Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;165(2):125-33.
- Peer-reviewed Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.
- Peer-reviewed Bonn-Miller MO, Loflin MJE, Thomas BF, et al. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 2017;318(17):1708-1709.
- Government U.S. Food and Drug Administration. What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding. FDA Consumer Updates, 2019. ↗
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.